Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation

被引：0
|
作者：
Dhanashree Ratra
Krishnakanta Roy
Sneha Giridhar
Sushant Madaan
机构：
[1] Medical Research Foundation,Department of Vitreoretinal Diseases
[2] Sankara Nethralaya,undefined
来源：
Ophthalmology and Therapy | 2022年 / 11卷
关键词：
Anti VEGF; Biosimilar; Comparison with bevacizumab; DME; nAMD; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：135 / 149
页数：14
相关论文
共 50 条
  • [21] Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity A Multicenter Study
    Patel, Nimesh A.
    Acaba-Berrocal, Luis A.
    Hoyek, Sandra
    Fan, Kenneth C.
    Martinez-Castellanos, Maria Ana
    Baumal, Caroline R.
    Harper, C. Armitage, III
    Berrocal, Audina M.
    OPHTHALMOLOGY, 2023, 130 (04) : 373 - 378
  • [22] Comparison of reactivation between ranibizumab and bevacizumab in aggressive retinopathy of prematurity: A retrospective case series
    Gangwe, Anil Babanrao
    Ekumankama, Chibuzo B.
    Singh, Abhishek
    Parchand, Swapnil Madhukar
    Agrawal, Deepshikha
    Azad, Raj Vardhan
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2025, 73 (SUPPL 1)
  • [23] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Feng, Xue-Feng
    Constable, Ian J.
    McAllister, Ian L.
    Isaacs, Timothy
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 85 - 88
  • [24] Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer
    Rhodes, Whitney
    DeClue, Richard W.
    Accortt, Neil A.
    Jin, Ran
    Sandschafer, Darcie
    Wertz, Debra
    Patel, Kashyap
    FUTURE ONCOLOGY, 2021, 17 (36) : 5119 - 5127
  • [25] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Ian J Constable
    Ian L McAllister
    Timothy Isaacs
    International Journal of Ophthalmology, 2011, (01) : 85 - 88
  • [26] Ranibizumab for the Treatment of Diabetic Macular Oedema in the Real-World Clinical Setting in Portugal: A Multicentre Study
    Farinha, Claudia
    Martins, Amelia
    Neves, Arminda
    Soares, Raquel
    Ruao, Miguel
    Ornelas, Mario
    Neves, Pedro
    Rodrigues, Filipa Gomes
    Coelho, Constanca
    Silva, Rufino
    OPHTHALMOLOGICA, 2019, 241 (01) : 1 - 8
  • [27] Comparison of Bevacizumab and Ranibizumab in the Treatment of Type 1 Retinopathy of Prematurity Affecting Zone 1
    Kimyon, Sabit
    Mete, Alper
    OPHTHALMOLOGICA, 2018, 240 (02) : 99 - 105
  • [28] Comparison of the efficacy of aflibercept, ranibizumab, and bevacizumab in an RPE/choroid organ culture
    Alexa Klettner
    Muhammed Recber
    Johann Roider
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 1593 - 1598
  • [29] Comparison of the efficacy of aflibercept, ranibizumab, and bevacizumab in an RPE/choroid organ culture
    Klettner, Alexa
    Recber, Muhammed
    Roider, Johann
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (10) : 1593 - 1598
  • [30] Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey
    Gunay, Murat
    Sukgen, Emine Alyamac
    Celik, Gokhan
    Kocluk, Yusuf
    CURRENT EYE RESEARCH, 2017, 42 (03) : 462 - 469
12345